Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
Author:
Affiliation:
1. Department of Surgery; University of Pittsburgh; Pittsburgh Pennsylvania
2. Department of Pathology; University of Pittsburgh; Pittsburgh Pennsylvania
3. Division Hematology/Oncology; University of Pittsburgh; Pittsburgh Pennsylvania
Funder
National Institutes of Health under the Ruth L. Kirschstein National Research Service Award
Publisher
Wiley
Subject
Oncology,General Medicine,Surgery
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.23392/fullpdf
Reference50 articles.
1. Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity;Eheman;Cancer,2012
2. Prognostic indicators for survival after resection of pancreatic adenocarcinoma;Geer;Am J Surg,1993
3. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma;Landry;J Surg Oncol,2010
4. Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration;Truty;J Am Coll Surg,2012
5. Borderline resectable pancreatic cancer: The importance of this emerging stage of disease;Katz;J Am Coll Surg,2008
Cited by 171 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Disparities in neoadjuvant chemotherapy for pancreatic adenocarcinoma with vascular involvement;Surgery Open Science;2024-08
2. Clinical practice guidelines for interventional treatment of pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024
3. A Case of Complete Remission from Pancreatic Cancer Following Palliative Chemotherapy;The Korean Journal of Pancreas and Biliary Tract;2023-10-31
4. Extended Radical Surgery for Pancreatic Cancer;The Pancreas;2023-08-04
5. Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going;Journal of Clinical Medicine;2023-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3